Please contact us for further information.
https://www.formosalab.com/
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Imatinib Mesylate</strong> is a small-molecule tyrosine kinase inhibitor used primarily in oncology. Manufactured via multi-step organic synthesis, its molecular formula is C<sub>29</sub>H<sub>31</sub>N<sub>7</sub>O·CH<sub>4</sub>SO<sub>3</sub>, with CAS No. 152486-40-9.</p>
<h3>Application</h3>
<ul>
<li>Treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).</li>
<li>Targeted therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).</li>
<li>R&D raw material for pharmaceutical formulation development and clinical trials.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store below 25°C in dry conditions to maintain stability. Handling requires PPE due to potential cytotoxicity; avoid inhalation or skin contact during industrial processing.</p>